BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2500497)

  • 21. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
    Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
    PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The content of free light-chain immunoglobulins in the cerebrospinal fluid and the importance of its determination for the differential diagnosis of multiple sclerosis].
    Totolian NA; Griazeva IV; Klimovich VB; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(2):49-53. PubMed ID: 7941891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
    J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free light chains in multiple sclerosis and infections of the CNS.
    DeCarli C; Menegus MA; Rudick RA
    Neurology; 1987 Aug; 37(8):1334-8. PubMed ID: 3112610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominance of oligoclonal IgG type lambda in CSF in aseptic meningitis.
    Frydén A; Link H
    Arch Neurol; 1979 Aug; 36(8):478-80. PubMed ID: 116631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.
    Desplat-Jégo S; Feuillet L; Pelletier J; Bernard D; Chérif AA; Boucraut J
    J Clin Immunol; 2005 Jul; 25(4):338-45. PubMed ID: 16133990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased occurrence of free immunoglobulin light chains in cerebrospinal fluid and serum in human immunodeficiency virus-1 infection.
    Elovaara I; Seppälä I; Kinnunen E; Laaksovirta H
    J Neuroimmunol; 1991 Dec; 35(1-3):65-77. PubMed ID: 1955573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis: assay of free immunoglobulin light chains.
    Ramsden DB
    Ann Clin Biochem; 2017 Jan; 54(1):5-13. PubMed ID: 27170023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive competitive-binding ELISAs for quantifying free kappa and lambda light chains in cerebrospinal fluid.
    Stanescu GL; Swick AR; Tuohy VK; Rudick RA
    J Clin Lab Anal; 1991; 5(3):206-11. PubMed ID: 1905748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid immunoelectrophoresis in multiple sclerosis.
    Kolar OJ; Rice PH; Jones FH; Defalque RJ; Kincaid J
    J Neurol Sci; 1980 Aug; 47(2):221-30. PubMed ID: 6774062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
    Rathbone E; Durant L; Kinsella J; Parker AR; Hassan-Smith G; Douglas MR; Curnow SJ
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1044-1049. PubMed ID: 29743290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of kappa free light chains in multiple sclerosis.
    Kaplan B; Ganelin-Cohen E; Golderman S; Livneh A
    Expert Rev Mol Diagn; 2019 Apr; 19(4):277-279. PubMed ID: 30795689
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoglobulin light chain patterns in the cerebrospinal fluid. A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G.
    Gallo P; Tavolato B; Bergenbrant S; Sidén A
    J Neurol Sci; 1989 Dec; 94(1-3):241-53. PubMed ID: 2515256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised double blind controlled trial of cyclosporin in multiple sclerosis.
    Rudge P; Koetsier JC; Mertin J; Mispelblom Beyer JO; Van Walbeek HK; Clifford Jones R; Harrison J; Robinson K; Mellein B; Poole T
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):559-65. PubMed ID: 2659736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis: free light chains in cerebrospinal fluid.
    Rudick RA; Peter DR; Bidlack JM; Knutson DW
    Neurology; 1985 Oct; 35(10):1443-9. PubMed ID: 3929159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical findings in multiple sclerosis. III. Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis.
    Bollengier F; Delmotte P; Lowenthal A
    J Neurol; 1976 Apr; 212(2):151-8. PubMed ID: 57227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligoclonal immunoglobulins, light chain ratios and free light chains in cerebrospinal fluid and serum from patients affected with various neurological diseases.
    Bollengier F; Rabinovitch N; Lowenthal A
    J Clin Chem Clin Biochem; 1978 Mar; 16(3):165-73. PubMed ID: 418140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation.
    Link H; Laurenzi MA
    Ann Neurol; 1979 Aug; 6(2):107-10. PubMed ID: 115379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.